Sources and Acquisition of Streptomycin Resistance in Erwinia
amylovora, the Fire Blight Pathogen
PURR FINAL REPORT
Project Title:
Sources and Acquisition of Streptomycin Resistance in Erwinia
amylovora, the Fire Blight Pathogen
Research Team:
Patricia McManus, Assistant Professor, Dept. Plant Pathology, 1630 Linden
Drive, UW-Madison, 608-265-2047, psm@plantpath.wisc.edu
Vi Best, Senior Research Specialist, Dept. Plant Pathology, 1630 Linden
Drive, UW-Madison, 608-262-2093, vmb@plantpath.wisc.edu
Other Funding:
CALS Institute for Pest and Pathogen Management
Duration:
June 1-December 31, 1999
PROJECT SUMMARY
Purpose of the Project:
To determine if plant-grade antibiotics contain bacterial DNA, specifically
genes for antibiotic resistance.
Relevance to FQPA:
Streptomycin and oxytetracycline, the only two antibiotics registered for
use on plants, are in Priority Group 3 for tolerance reassessment. The use of
antibiotics in agriculture is being scrutinized closely as the antibiotic
resistance problems in hospitals and communities worsen. One concern is that
antibiotic formulations for plant use might be impure, containing antibiotic
resistance genes from the Streptomyces bacteria used to produce the
antibiotics. Then by spraying the antibiotic onto apple trees, growers might
be providing antibiotic resistance genes that can be taken up by Erwinia
amylovora, the fire blight pathogen. If E. amylovora becomes
resistant to streptomycin and oxytetracycline, control becomes even more
difficult.
Relevance to Wisconsin Agriculture:
Wisconsin has about 325 apple orchards covering about 6500 acres. The most
common varieties (McIntosh, Red Delicious, Cortland) are not highly
susceptible to fire blight, and antibiotics are rarely used on these trees.
However, there is significant acreage of the highly susceptible Golden
Delicious, Gala, Paulared, and Idared. A new favorite, Honeycrisp, is also
highly susceptible. Nearly all the dwarfing rootstocks, which have become
popular in the past decade, are susceptible to fire blight. Thus, many growers
rely on streptomycin for control of fire blight. There are no hard figures for
the economic impact of fire blight in Wisconsin. However, if left unchecked
the disease can completely destroy a young, high-density planting, causing
$5000-10,000 loss per acre in a single season.
Results:
We did not detect DNA in several samples of plant-grade streptomycin
products. The two methods used (DNA staining with a fluorescent marker
followed by microscopy and the polymerase chain reaction [PCR]) are highly
sensitive techniques that were used by other researchers to detect DNA in
veterinary and reagent grade antibiotics. In order to verify that our
techniques were adequate, we "spiked" samples with known amounts of
bacteria. The lower limit of detection was 300 cells of Streptomyces
bacteria per milligram of antibiotic formulation. There seemed to be some
inhibition of PCR by streptomycin products, possibly because the antibiotic
bound DNA, or because product additives inhibited enzyme activity in PCR.
Interpretation/Conclusions:
We conclude that DNA, including antibiotic resistance genes, is either
absent or present at low, undetectable levels in plant-grade antibiotic
formulations. It is unlikely that growers are enriching the environment with
antibiotic resistance genes when they spray streptomycin to control fire
blight.
Outreach Activities:
This short-term project was not intended to produce a lot of information
for outreach directly to growers. Rather, the data is more directly relevant
to defending the use of antibiotics on plants, a practice that has come under
attack in recent years. This research was presented briefly by McManus at the
annual meeting of the American Association for the Advancement of Science in
February 2000. In addition to scientists, several policy makers and reporters
were present. Currently McManus is co-authoring an article on plant-use of
antibiotics to appear online at http://www.scisoc.org in June 2000.
Links to Other Projects:
This project complemented a survey of Wisconsin apple orchards for
streptomycin-resistant strains of Erwinia amylovora conducted in 1998.
We have not been successful at getting federal funds at the level needed to do
further work on this project. Thus, for the time being, we are not pursing
this work further.
|